Leuven, Belgium

Sona Kovachova

This inventor holds 1 USPTO granted patent. Top assignee: Katholieke Universiteit Leuven. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sona Kovachova. Retrieved from https://idiyas.com/inventor/sona-kovachova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sona Kovachova: Innovator in Pharmaceutical Chemistry

Introduction

Sona Kovachova is a prominent inventor based in Leuven, Belgium. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development efforts.

Latest Patents

Kovachova holds a patent for GAK modulators, which pertains to a class of novel isothiazolo[4,3-b]pyridine derivatives. This invention includes a method for their preparation and pharmaceutical compositions that comprise these derivatives along with pharmaceutically acceptable excipients. The novel compounds are intended for use as biologically active ingredients, specifically as medicaments for treating various disorders and pathologic conditions, including cell-proliferative and neurodegenerative diseases.

Career Highlights

Sona Kovachova is affiliated with Katholieke Universiteit Leuven, also known as KU Leuven R&D. Her work at this esteemed institution has allowed her to explore and develop groundbreaking pharmaceutical solutions that address critical health issues.

Collaborations

Throughout her career, Kovachova has collaborated with notable colleagues, including Piet Herdewijn and Steven De Jonghe. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.

Conclusion

Sona Kovachova's contributions to pharmaceutical chemistry through her patent on GAK modulators exemplify her commitment to addressing significant medical challenges. Her work continues to inspire advancements in the treatment of various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…